- Issuer ticker
-
ATRA
- Reported as of
-
04 Sep 2026
- Net transaction value
-
+$999,994
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
04 Sep 2026, 18:20:04 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Brian Cherry
Key filing fact
Brian N. Cherry filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 04 Sep 2026.
Key facts
- This page summarizes Brian N. Cherry's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Sep 2026, 18:20.
Change
- Previous filing in this sequence was filed on 15 Jun 2026.
- Current net transaction value: +$999,994.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001290922
Primary reporting owner
Cherry Brian N
- Relationship
-
Director
- Address
- C/O ATARA BIOTHERAPEUTICS, INC., 1280 RANCHO CONEJO BOULEVARD, THOUSAND OAKS
- Signature
- /s/ Brian Cherry
- Signature date
- 04 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATRA
transaction
Common Stock
Purchase
- Transaction value
- $999,994
- Shares
- +104,166
- Change %
- +167%
- Price
-
$9.60
- Shares after
- 166,486
- Date
- 04 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney